Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

ClinicalTrials.gov ID: NCT01309737

Public ClinicalTrials.gov record NCT01309737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Site, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy And Safety Of 2 Oral Doses Of CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this study is to compare the effects of CP-690,550 with the effects of placebo in patients being treated for moderate to severe chronic plaque psoriasis. This one-year study will also evaluate the safety and tolerability of CP-690,550 versus placebo.

Study identification

NCT ID
NCT01309737
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
960 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Apr 2013 (Actual)
Last update posted
Sep 19, 2014

2011 – 2013

United States locations

U.S. sites
44
U.S. states
22
U.S. cities
36
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield California 93309 —
University of California San Diego La Jolla California 92037 —
Dermatology Research Associates Los Angeles California 90045 —
Expresscare Medical (X-Rays only) Los Angeles California 90045 —
MedDerm Associates San Diego California 92103 —
University of California San Diego San Diego California 92122 —
Healthcare Partners Medical Group Torrance California 90503 —
North Florida Dermatology Associates, PA Jacksonville Florida 32204 —
Dermatologic Surgery Specialists, PC Macon Georgia 31217 —
Sherman Immediate Care Center (Imaging Only) Algonquin Illinois 60102 —
Schaumburg Dermatology Schaumburg Illinois 60194 —
NorthShore University HealthSystem - Division of Dermatology Skokie Illinois 60077 —
Dundee Dermatology West Dundee Illinois 60118 —
Hudson Dermatology Evansville Indiana 47714 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Somerset Skin Centre - Dermcenter Troy Michigan 48084 —
University of Minnesota - Department of Dermatology Minneapolis Minnesota 55455 —
Saint Louis University - Department of Dermatology St Louis Missouri 63104 —
Central Dermatology, PC St Louis Missouri 63117 —
Bettencourt Skin Center Henderson Nevada 89074 —
Dartmouth Hitchcock Medical Center - Section of Dermatology Lebanon New Hampshire 03756 —
Comprehensive Clinical Research Berlin New Jersey 08009 —
The Rockefeller University New York New York 10065 —
University of North Carolina at Chapel Hill Hospital Chapel Hill North Carolina 27514 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27516 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27104 —
Radiant Research, Inc. Columbus Ohio 43212 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Oregon Health & Science University Portland Oregon 97239 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Health Concepts Rapid City South Dakota 57702 —
Arlington Research Center, Inc. Arlington Texas 76011 —
Austin Dermatology Associates Austin Texas 78705 —
Dermatology Treatment & Research Center, PA Dallas Texas 75230 —
InSight Diagnostic Center Dallas Texas 75243 —
Center for Clinical Studies Houston Texas 77030 —
Suzanne Bruce and Associates, PA Houston Texas 77056 —
Office of Mark S. Lee, MD San Antonio Texas 78229 —
Progressive Clinical Research, PA San Antonio Texas 78229 —
Center for Clinical Studies Webster Texas 77598 —
Virginia Clinical Research, Inc. Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01309737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2014 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01309737 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →